Molecular Mechanisms of Mitral Regurgitation-Aim 2
NCT01052532 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65
Last updated 2010-12-02
Summary
The investigators hypothesize that MR in humans is characterized by adrenergic overdrive, reactive nitrogen species, and an antifibrotic phenotype that relate to the severity of adverse LV remodeling prior to surgery and outcome after valve repair.
Conditions
- Mitral Regurgitation
Sponsors & Collaborators
-
University of Alabama at Birmingham
lead OTHER
Principal Investigators
-
Louis J Dell'Italia, M.D · University of Alabama at Birmingham
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-06-30
- Primary Completion
- 2010-11-30
- Completion
- 2010-11-30
Countries
- United States
Study Locations
More Related Trials
-
An Integrative-"Omics" Study of Cardiomyopathy Patients for Diagnosis and Prognosis in China
NCT03076580 ·Status: UNKNOWN
-
Biomarkers in Aortic Stenosis - B.A.S.S.
NCT01334801 ·Status: COMPLETED
-
Innovation Research of Differentiation and Treatment Methods Based on CHD Phlegm and Blood Stasis Syndrome
NCT02967718 ·Status: UNKNOWN
-
Metabolomic Study of All-age Cardiomyopathy
NCT03061994 ·Status: UNKNOWN
-
Characterization of Sympathetic Nerve Activity in Stress Cardiomyopathy
NCT01048125 ·Status: TERMINATED ·Phase: NA
-
Risk Stratification of Heart Failure in Cardiomyopathies.
NCT02941315 ·Status: COMPLETED ·Phase: PHASE1
-
Lymphatic Function in Patients With Secondary Tricuspid Valve Regurgitation
NCT04595448 ·Status: COMPLETED
-
Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management
NCT04521790 ·Status: RECRUITING
-
Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease
NCT01099982 ·Status: RECRUITING
-
Evaluating Microvascular Dysfunction in Symptomatic Patients With HypertroPhic CaRdiomyopathy
NCT02994615 ·Status: COMPLETED
-
Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism
NCT00181259 ·Status: RECRUITING
-
Analysis of Heart Muscle Function Following Exercise in Patients With Heart Disease
NCT00001528 ·Status: COMPLETED
-
Markers and Response to Cardiac Resynchronization Therapy
NCT01519908 ·Status: COMPLETED
-
Speckle Tracking Imaging and Realtime 3 Dimensional Echocardiograhy to Study LV Function and Remodeling After Acute Myocardial Infarction (AMI)
NCT00745680 ·Status: UNKNOWN
-
Myocarditis Causing Premature Ventricular Contractions:Insights From the MAVERIC Registry
NCT05158751 ·Status: NOT_YET_RECRUITING
-
Energetic Abnormalities in Heart Failure With Preserved Ejection Fraction
NCT00628082 ·Status: UNKNOWN
-
Hostility and Coronary Risk--Role of Weak Vagal Function
NCT00005337 ·Status: COMPLETED
-
Intracardiac Flow Assessment in Cardiac Amyloidosis
NCT05379101 ·Status: RECRUITING
-
Evaluation of Patients With Heart Disease Not Eligible for Research Protocols
NCT00001458 ·Status: COMPLETED
-
"Multifactorial Risk Stratification in Acute and Chronic Cardiovascular Disease"
NCT05472207 ·Status: RECRUITING
-
Heart Rate Variability and Sudden Cardiac Death
NCT00005235 ·Status: COMPLETED
-
Local Inflammation in Arrhythmogenic Right Ventricular Cardiomyopathy
NCT05209776 ·Status: RECRUITING ·Phase: NA
-
Idiopathic Dilated Cardiomyopathy
NCT00005201 ·Status: COMPLETED
-
Risk Stratification Value of Biomarkers in Patients With Myocarditis
NCT06010199 ·Status: RECRUITING
-
Cardiac Autonomic Function in Women with Microvascular Coronary Dysfunction
NCT01568177 ·Status: COMPLETED ·Phase: NA